Cargando…

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis

OBJECTIVES: With the tools available currently, confirming the diagnosis of inclusion body myositis (IBM) can be difficult. Many patients are initially misdiagnosed with polymyositis (PM). In this observational study at a UK adult neuromuscular centre, we investigated whether amyloid positron emissi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lilleker, James B, Hodgson, Richard, Roberts, Mark, Herholz, Karl, Howard, James, Hinz, Rainer, Chinoy, Hector
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Myositis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517800/ https://www.ncbi.nlm.nih.gov/pubmed/30760470 http://dx.doi.org/10.1136/annrheumdis-2018-214644

Ejemplares similares

Immune‐Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA–DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum
por: Rothwell, Simon, et al.
Publicado: (2017)

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups
por: Rothwell, Simon, et al.
Publicado: (2019)

Muscle Weakness in Myositis: MicroRNA‐Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies
por: Kinder, Travis B., et al.
Publicado: (2020)

Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies
por: Zhou, Danlei, et al.
Publicado: (2023)

Aberrant Muscle Antigen Exposure in Mice Is Sufficient to Cause Myositis in a Treg Cell–Deficient Milieu
por: Young, Nicholas A, et al.
Publicado: (2013)

Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments
por: Kawahata, Kimito, et al.
Publicado: (2023)

Genetics in inclusion body myositis
por: Rothwell, Simon, et al.
Publicado: (2017)

Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies
por: Che, Weng Ian, et al.
Publicado: (2021)

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I
por: Zhang, Lu, et al.
Publicado: (2023)

Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease
por: Chen, Xixia, et al.
Publicado: (2023)

Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis
por: Wilkinson, Meredyth G Ll, et al.
Publicado: (2023)

Intramuscular lesions in musculoskeletal MRI as a favourable prognostic sign in patients with anti-MDA5 antibody-positive dermatomyositis
por: Oto, Yohsuke, et al.
Publicado: (2023)

Severe case of rhabdomyolysis following jellyfish envenomation in the Mediterranean Sea
por: Buscetta, Giorgio, et al.
Publicado: (2023)

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case–control study
por: Pijnenburg, Luc, et al.
Publicado: (2023)

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab
por: Ostendorf, Lennard, et al.
Publicado: (2023)

Dual-phase [18F]florbetapir in frontotemporal dementia
por: Asghar, Michael, et al.
Publicado: (2018)

Long‐term strength and functional status in inclusion body myositis and identification of trajectory subgroups
por: Oldroyd, Alexander G. S., et al.
Publicado: (2020)

Update in inclusion body myositis
por: Machado, Pedro, et al.
Publicado: (2013)

Lacrimal gland uptake on F-18 florbetapir amyloid positron emission tomography scan
por: Itani, Malak, et al.
Publicado: (2017)

Exploring challenges in the management and treatment of inclusion body myositis
por: Skolka, Michael P., et al.
Publicado: (2023)

A Masquerade of Infectious Myositis as Polymyositis
por: Mank, Victoria Marie Ferreira, et al.
Publicado: (2020)

Patient-centred standards of care for adults with myositis
por: Lilleker, James B., et al.
Publicado: (2017)

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
por: To, Fergus, et al.
Publicado: (2019)

Update in juvenile myositis
por: Nistala, Kiran, et al.
Publicado: (2013)

Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies
por: Oldroyd, Alexander, et al.
Publicado: (2018)

Reference tissue normalization in longitudinal (18)F-florbetapir positron emission tomography of late mild cognitive impairment
por: Shokouhi, Sepideh, et al.
Publicado: (2016)

Update on muscle imaging in myositis
por: Tan, Ai Lyn, et al.
Publicado: (2023)

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes
por: Weston, Philip S.J., et al.
Publicado: (2015)

Application of Haralick texture features in brain [(18)F]-florbetapir positron emission tomography without reference region normalization
por: Campbell, Desmond L, et al.
Publicado: (2017)

Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis
por: Teipel, Stefan J., et al.
Publicado: (2021)

Cortical florbetapir-PET amyloid load in prodromal Alzheimer’s disease patients
por: Saint-Aubert, Laure, et al.
Publicado: (2013)

Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis
por: Rothwell, Simon, et al.
Publicado: (2019)

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
por: Cruellas, Marcela Gran Pina, et al.
Publicado: (2013)

Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis
por: Temmoku, Jumpei, et al.
Publicado: (2019)

Nailfold capillaroscopy changes with disease activity in patients with inflammatory myositis including overlap myositis, pure dermatomyositis, and pure polymyositis
por: Shenavandeh, Saeedeh, et al.
Publicado: (2022)

Comments: Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
por: Ferreira, Bruno Silva de Araujo, et al.
Publicado: (2022)

Applying Hickam’s dictum: a case of adult-onset LGMD2I muscular dystrophy and long QT syndrome
por: Sheikh, Ali S F, et al.
Publicado: (2023)

Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer’s Disease: A PET Study
por: Planton, Mélanie, et al.
Publicado: (2020)

Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies
por: Hiniker, Annie, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a491r4om39f5sthp5g4cekohls